MedPath

LIDOCAINE HYDROCHLORIDE

LIDOCAINEHYDROCHLORIDETOPICAL SOLUTION, USP 4%

Approved
Approval ID

521d6be9-72d9-4662-a62e-afc70197d620

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Mar 10, 2022

Manufacturers
FDA

Morton Grove Pharmaceuticals, Inc.

DUNS: 801897505

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

lidocaine hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code60432-465
Application NumberANDA087881
Product Classification
M
Marketing Category
C73584
G
Generic Name
lidocaine hydrochloride
Product Specifications
Route of AdministrationTOPICAL
Effective DateMarch 10, 2022
FDA Product Classification

INGREDIENTS (5)

SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
LIDOCAINE HYDROCHLORIDEActive
Quantity: 40 mg in 1 mL
Code: V13007Z41A
Classification: ACTIR
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3
Classification: IACT
METHYLPARABENInactive
Code: A2I8C7HI9T
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

LIDOCAINE HYDROCHLORIDE - FDA Drug Approval Details